All Cancer Microbiology articles – Page 5
-
NewsEngineers take a closer look at how a plant virus primes the immune system to fight cancer
Scientists took a closer look at how the cowpea mosaic virus (CPMV), unlike other plant viruses, is uniquely effective at activating the body’s immune system to recognize and attack cancer cells.
-
NewsCan a compound produced by deep-sea bacteria treat cancer?
Investigators purified a long-chain sugar molecule, or exopolysaccharide, from deep-sea bacteria and demonstrated that it triggers pyroptosis—an inflammatory form of programmed cell death—to inhibit tumor growth.
-
NewsFermented stevia leaf extract has potential as anticancer treatment, researchers find
Stevia may provide more benefits than as a zero-calorie sugar substitute. When fermented with bacteria isolated from banana leaves, stevia extract kills off pancreatic cancer cells but doesn’t harm healthy kidney cells, according to a research team.
-
NewsTumor-targeting fluorescent bacteria illuminate cancer for precision surgery
Researchers have developed a next-generation intraoperative imaging platform using engineered beneficial bacteria that emit fluorescence specifically at tumor sites. This illuminates tumors like a neon sign during surgery, enabling more precise resection and reducing risk of recurrence.
-
NewsHow tumor microbes shape cancer: New insights into microbial diversity in the tumor microenvironment
Intratumoral microbiota—the microbial populations residing within solid tumors—have emerged as pivotal components of the tumor microenvironment (TME), influencing tumor initiation, progression, and therapeutic outcomes.
-
NewsMichael Danquah named Fellow of Royal Society of Biology
Michael Danquah, a professor in the Department of Chemical and Biomolecular Engineering and the associate dean for academic and student affairs at the University of Tennessee at Knoxville, has been elected as a Fellow of the Royal Society of Biology.
-
NewsPenicillium hispanicum yields discovery of new bianthrones and chlorinated bianthrones with cytotoxic activity against cancer cells
A new study reports the discovery of three novel racemic bianthrones from Penicillium hispanicum LA032 using HSQC-based DeepSAT, as well as their cytotoxic evaluation and mechanistic investigation through network pharmacology.
-
NewsCohort data from Denmark show real-world evidence of stable protection against HPV-related cervical cancer
Denmark has been offering free vaccination against human papillomavirus (HPV) to girls since 2008. New data show vaccination has effectively reduced infections with cancerogenic HPV 16/18 types covered by the vaccine, indicating population immunity.
-
NewsGut microbes key to understanding how exercise boosts cancer immunity
A new study shows how exercise improves cancer outcomes and enhances response to immunotherapy in mice by reshaping the gut microbiome. These benefits are driven by a specific compound called formate, which is produced by gut bacteria in exercised mice.
-
NewsCancer-fighting herpes virus shown to be an effective treatment for some advanced melanoma
A genetically engineered herpes simplex virus, when combined with immunotherapy, reduces or eliminates tumors in one-third of clinical trial patients, according to a new study.
-
NewsResearchers find compound that inhibits cutaneous HPVs
Researchers have identified a promising new compound that inhibits cutaneous HPV. In lab studies, the compound inhibited viral replication genes in cutaneous HPVs without damaging host cells.
-
NewsAdults who have survived childhood cancer are at increased risk of severe COVID-19
People who have survived cancer as children are at higher risk of developing severe COVID-19, even decades after their diagnosis. This is shown by a new study from Karolinska Institutet published in the journal The Lancet Regional Health – Europe.
-
NewsNew immunotherapy strategy targets difficult-to-treat brain tumors with gut microbiota
Researchers have demonstrated a new therapeutic strategy that can enhance the efficacy of immunotherapy for brain tumors by utilizing gut microbes and their metabolites. This also opens up possibilities for developing microbiome-based immunotherapy supplements in the future.
-
NewsGut microbes may help in recognizing and treating pancreatic cancer
A new international cooperation study indicates that in the future pancreatic cancer may be detected at an early stage with the help of gut microbes. Gut microbes may also offer solutions for therapy development.
-
NewsFusobacterium nucleatum in colorectal cancer: Ally mechanism and targeted therapy strategies
A recent review systematically outlines the pathogenic mechanisms of Fusobacterium nucleatum in colorectal cancer and summarizes both current and emerging strategies for its therapeutic targeting.
-
News2 million Americans with hepatitis C at risk if Supreme Court cancels free preventative care, study finds
A ruling overturning the Affordable Care Act (ACA) coverage mandate has the potential to dramatically change the landscape for early detection and treatment of hepatitis C virus in the U.S., according to a new paper.
-
NewsHPV drives tumor development in rare nasal cancers
Human papillomavirus (HPV) can drive tumor development in some rare sinonasal squamous cell carcinomas (SNSCCs), according to a new comprehensive study of these tumors from investigators who also identified common mutations among these cancers and a potential combination treatment.
-
NewsUrgent need to quantify role of fungal toxins in rising liver cancer rates in Ghana
There’s an urgent need to quantify the role of aflatoxins, found on agricultural crops, such as maize and peanuts, in the escalating rates of liver cancer in Ghana, as well as elsewhere in Africa and Asia, concludes a commentary.
-
NewsGlobal phage experts converge in Berlin to shape the future of antimicrobial medicine
The 8th World Congress on Targeting Phage Therapy (June 10–11, 2025) returns to Berlin, bringing together over 75 international speakers and contributors from 27 countries.
-
NewsResearchers engineer a herpes virus to turn on T cells for immunotherapy
Researchers have identified herpes virus saimiri, which infects the T cells of squirrel monkeys, as a source of proteins that activate pathways in T cells that are needed to promote T cell survival - a promising tool in the fight against cancer.